Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy Verona Pharma stock | $5.82

Learn how to easily invest in Verona Pharma stock.

Verona Pharma plc
NASDAQ: VRNA - USD
BIOTECHNOLOGY
$5.97
-$0.15 (-2.45%)

Verona Pharma plc is a biotechnology business based in the US. Verona Pharma shares (VRNA) are listed on the NASDAQ and all prices are listed in US Dollars. Verona Pharma employs 25 staff and has a market cap (total outstanding shares value) of 0.00.

How to buy shares in Verona Pharma

  1. Compare share trading platforms.Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – VRNA – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

Verona Pharma stock price (NASDAQ: VRNA)

Use our graph to track the performance of VRNA stocks over time.

Verona Pharma shares at a glance

Information last updated 2021-07-28.
Latest market close$5.82
52-week range$5.40 - $9.72
50-day moving average $6.31
200-day moving average $7.38
Wall St. target price$19.00
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) $-2.34

Buy Verona Pharma shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Asset types Option trade fee Annual fee Signup bonus
Robinhood
Stocks, Options, ETFs
$0
0%
Free stock (chosen randomly with a value anywhere between $2.50 and $200)
Sign up using the "go to site" link
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
Sofi Invest
Stocks, ETFs, Cryptocurrency
N/A
0%
Get one free stock worth up to $1,000
Open an account
A free way to invest in stocks, ETFs and crypto.
Public
Stocks, ETFs
N/A
$0 per month
Download and sign up with Public.com; approved accounts receive a free stock slice worth up to $70, selected from 9 popular stocks.
Open an account
Commission-free trading in stocks and ETFs with a social networking twist.
Webull
Stocks, Options, ETFs
$0
0%
Get one free stock valued between $3.00 and $300 when you open an account, one more with a deposit
Open an account
Margin financing rates start at 3.99%. No monthly subscription fees for margin.
J.P. Morgan Self-Directed Investing
Stocks, Bonds, Options, Mutual funds, ETFs
$0 + $0.65/contract
0%
N/A
INVESTMENT AND INSURANCE PRODUCTS ARE: NOT A DEPOSIT • NOT FDIC INSURED • NO BANK GUARANTEE • MAY LOSE VALUE
Moomoo
Stocks, Options, ETFs
$0
$0 per year
N/A
Trade stocks on the US, Hong Kong, Shanghai and Shenzhen markets.
loading

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Verona Pharma stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Verona Pharma price performance over time

Historical closes compared with the close of $5.82 from 2021-05-26

1 week (2021-07-25) N/A
1 month (2021-07-02) -2.51%
3 months (2021-05-05) -7.77%
6 months (2021-02-01) N/A
1 year (2020-08-01) N/A
2 years (2019-08-01) N/A
3 years (2018-08-01) N/A
5 years (2016-08-01) N/A

Verona Pharma financials

Gross profit TTM $0
Return on assets TTM -37.8%
Return on equity TTM -72.44%
Profit margin 0%
Book value $2.97
Market capitalisation $347.7 million

TTM: trailing 12 months

Shorting Verona Pharma shares

There are currently 206,475 Verona Pharma shares held short by investors – that's known as Verona Pharma's "short interest". This figure is 12.6% down from 236,166 last month.

There are a few different ways that this level of interest in shorting Verona Pharma shares can be evaluated.

Verona Pharma's "short interest ratio" (SIR)

Verona Pharma's "short interest ratio" (SIR) is the quantity of Verona Pharma shares currently shorted divided by the average quantity of Verona Pharma shares traded daily (recently around 62758.358662614). Verona Pharma's SIR currently stands at 3.29. In other words for every 100,000 Verona Pharma shares traded daily on the market, roughly 3290 shares are currently held short.

However Verona Pharma's short interest can also be evaluated against the total number of Verona Pharma shares, or, against the total number of tradable Verona Pharma shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Verona Pharma's short interest could be expressed as 0% of the outstanding shares (for every 100,000 Verona Pharma shares in existence, roughly 0 shares are currently held short) or 0.0063% of the tradable shares (for every 100,000 tradable Verona Pharma shares, roughly 6 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Verona Pharma.

Find out more about how you can short Verona Pharma stock.

Verona Pharma share dividends

We're not expecting Verona Pharma to pay a dividend over the next 12 months.

Verona Pharma share price volatility

Over the last 12 months, Verona Pharma's shares have ranged in value from as little as $5.4 up to $9.722. A popular way to gauge a stock's volatility is its "beta".

VRNA.US volatility(beta: 0.51)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Verona Pharma's is 0.5145. This would suggest that Verona Pharma's shares are less volatile than average (for this exchange).

Verona Pharma overview

Verona Pharma plc, a clinical stage biopharmaceutical company, focuses on development and commercialization of therapies for the treatment of respiratory diseases with unmet medical needs. Its product candidate is ensifentrine, an inhaled and dual inhibitor of the phosphodiesterase (PDE) 3 and PDE4 enzymes that acts as both a bronchodilator and an anti-inflammatory agent in a single compound, which is in Phase 2 clinical trials for the treatment of chronic obstructive pulmonary disease, asthma, and cystic fibrosis. The company is developing ensifentrine in three formulations, including nebulizer, dry powder inhaler, and pressurized metered-dose inhaler. It also focuses on developing ensifentrine for the treatment of COVID-19. Verona Pharma plc was founded in 2005 and is headquartered in London, the United Kingdom. .

Frequently asked questions

What percentage of Verona Pharma is owned by insiders or institutions?
Currently 10.377% of Verona Pharma shares are held by insiders and 64.897% by institutions.
How many people work for Verona Pharma?
Latest data suggests 25 work at Verona Pharma.
When does the fiscal year end for Verona Pharma?
Verona Pharma's fiscal year ends in December.
Where is Verona Pharma based?
Verona Pharma's address is: 3 More London Riverside, London, United Kingdom, SE1 2RE
What is Verona Pharma's ISIN number?
Verona Pharma's international securities identification number is: US9250501064
What is Verona Pharma's CUSIP number?
Verona Pharma's Committee on Uniform Securities Identification Procedures number is: 925050106

More guides on Finder

Ask an Expert

You are about to post a question on finder.com:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site